You are here

  • Home
  • Archive
  • Volume 61, Issue Suppl 2
  • PMO-169 Pegylated interferon α, Nitazoxanide, Telapravir, Ribavirin, in genotype 1 undergoing prior experienced chronic hepatitis C patients: a randomised placebo control clinical pilot trial (I N T R I G U E C) interim

Citation Tools

Article menu

Download PDFPDF

Posters
Viral hepatitis
PMO-169 Pegylated interferon α, Nitazoxanide, Telapravir, Ribavirin, in genotype 1 undergoing prior experienced chronic hepatitis C patients: a randomised placebo control clinical pilot trial (I N T R I G U E C) interim
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Basu P, Nair T, Farhat S, et al
PMO-169 Pegylated interferon α, Nitazoxanide, Telapravir, Ribavirin, in genotype 1 undergoing prior experienced chronic hepatitis C patients: a randomised placebo control clinical pilot trial (I N T R I G U E C) interim
Gut 2012;61:A142.